Occupe actuellement des postes chez Thermo Fisher Scientific Inc and Editas Medicine Inc
Position | Company | Period |
---|---|---|
Director | Thermo Fisher Scientific Inc | 8 novembre 2018 - |
Independent Chairman of the Board | Editas Medicine Inc | 27 mars 2018 - |
Independent Director | Insulet Corp | 9 août 2017 - 25 janvier 2019 |
Independent Director | PerkinElmer Inc | 1 janvier 2004 - 28 avril 2015 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2022-01-04 | 2022-01-03 |
Editas Medicine Inc
(EDIT)
|
V Vente |
18 252
-19.4%
26,95491 979 USD |
18 252 -19.4% | 26,95 | 491 979 USD | |
2021-10-20 | 2021-10-18 |
Editas Medicine Inc
(EDIT)
|
V Vente |
13 805
-19.3%
38,03525 033 USD |
13 805 -19.3% | 38,03 | 525 033 USD | |
2021-03-04 | 2021-03-02 |
Editas Medicine Inc
(EDIT)
|
A Achat |
25 000
+250.0%
46,271 156 800 USD |
25 000 +250.0% | 46,27 | 1 156 800 USD | |
2004-10-20 | 2004-10-18 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-3.8%
57,8186 711 USD |
1 500 -3.8% | 57,81 | 86 711 USD | |
2004-10-20 | 2004-10-18 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-3.7%
58,0587 073 USD |
1 500 -3.7% | 58,05 | 87 073 USD | |
2004-10-20 | 2004-10-18 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-3.6%
57,5086 250 USD |
1 500 -3.6% | 57,50 | 86 250 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 000
-2.3%
60,0060 000 USD |
1 000 -2.3% | 60,00 | 60 000 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-3.4%
59,9589 925 USD |
1 500 -3.4% | 59,95 | 89 925 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 325
-2.9%
60,3379 937 USD |
1 325 -2.9% | 60,33 | 79 937 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
175
-100.0%
60,3310 558 USD |
175 -100.0% | 60,33 | 10 558 USD | |
2004-10-13 | 2004-10-11 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-89.6%
60,1290 180 USD |
1 500 -89.6% | 60,12 | 90 180 USD | |
2004-10-05 | 2004-10-04 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 000
-37.4%
62,3862 380 USD |
1 000 -37.4% | 62,38 | 62 380 USD | |
2004-10-05 | 2004-10-04 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-35.9%
62,7794 158 USD |
1 500 -35.9% | 62,77 | 94 158 USD | |
2004-10-05 | 2004-10-04 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-26.4%
62,8594 268 USD |
1 500 -26.4% | 62,85 | 94 268 USD | |
2004-10-05 | 2004-10-04 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-20.9%
62,4893 723 USD |
1 500 -20.9% | 62,48 | 93 723 USD | |
2004-07-27 | 2004-07-26 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-2.6%
53,4480 157 USD |
1 500 -2.6% | 53,44 | 80 157 USD | |
2004-07-27 | 2004-07-26 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-2.5%
53,3580 025 USD |
1 500 -2.5% | 53,35 | 80 025 USD | |
2004-07-27 | 2004-07-19 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-2.6%
53,5180 259 USD |
1 500 -2.6% | 53,51 | 80 259 USD | |
2004-07-20 | 2004-07-19 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-2.4%
57,9686 933 USD |
1 500 -2.4% | 57,96 | 86 933 USD | |
2004-07-20 | 2004-07-19 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-2.4%
57,9086 849 USD |
1 500 -2.4% | 57,90 | 86 849 USD | |
2004-07-20 | 2004-07-19 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-2.3%
57,9286 877 USD |
1 500 -2.3% | 57,92 | 86 877 USD | |
2004-07-15 | 2004-07-13 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 000
-1.5%
60,7060 700 USD |
1 000 -1.5% | 60,70 | 60 700 USD | |
2004-07-15 | 2004-07-13 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-2.2%
60,5090 755 USD |
1 500 -2.2% | 60,50 | 90 755 USD | |
2004-07-15 | 2004-07-13 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-2.2%
60,4890 723 USD |
1 500 -2.2% | 60,48 | 90 723 USD | |
2004-07-15 | 2004-07-13 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-2.1%
60,6991 037 USD |
1 500 -2.1% | 60,69 | 91 037 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 000
-1.4%
62,0762 070 USD |
1 000 -1.4% | 62,07 | 62 070 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-2.1%
61,9992 985 USD |
1 500 -2.1% | 61,99 | 92 985 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
925
-1.3%
61,9857 335 USD |
925 -1.3% | 61,98 | 57 335 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
575
-100.0%
61,9835 641 USD |
575 -100.0% | 61,98 | 35 641 USD | |
2004-07-09 | 2004-07-06 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-72.3%
63,9795 959 USD |
1 500 -72.3% | 63,97 | 95 959 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 000
-3.3%
61,3261 320 USD |
1 000 -3.3% | 61,32 | 61 320 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-4.7%
61,2991 932 USD |
1 500 -4.7% | 61,29 | 91 932 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-4.5%
61,2691 896 USD |
1 500 -4.5% | 61,26 | 91 896 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
VP Vente planifiée |
1 500
-4.3%
61,3792 051 USD |
1 500 -4.3% | 61,37 | 92 051 USD | |
2004-05-14 | 2004-05-14 |
PerkinElmer Inc
(PKI)
|
A Achat |
5 000
+124.4%
18,3391 650 USD |
5 000 +124.4% | 18,33 | 91 650 USD |